EP 492 Outcomes in Robotic Redo Cardiac Surgery: A Novel Systematic Review and Meta-Analysis

Clicks: 1
ID: 323872
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #105 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims Redo cardiac surgery via resternotomy is technically challenging due to pericardial adhesions. Robotic techniques offer a minimally invasive alternative but pooled outcomes are limited. This review evaluates clinical outcomes of robotic redo cardiac surgery, focusing on mitral valve reinterventions. Methods A PRISMA-compliant systematic review was performed across PubMed, Scopus, Embase, MEDLINE and Web of Science. Meta-analyses focused on the robotic redo mitral surgery subgroup. Primary outcomes included in-hospital mortality (IHM), cardiopulmonary bypass (CPB) time and in-hospital length of stay (LOS). IHM was pooled using Freeman-Tukey double arcsine transformation. CBP time and LOS were analysed using DerSimonian-Laird random-effects models. Outcomes for tricuspid surgery and coronary artery bypass grafting (CABG) were assessed qualitatively. Results Eight studies met the inclusion criteria. In the mitral subgroup, pooled IHM was 2% (95% CI: 0-4.1%), with high consistency across cohorts (I2 = 0%, p = 0.95). Pooled mean CPB time was 149.2 minutes (95% CI: 113.1-185.3) and LOS was 7.4 days (95% CI: 5.07-9.73), both with high heterogeneity, in studies that reported these outcomes. Comparative data from one study suggested lower mortality in robotic redo mitral surgery compared to resternotomy. Qualitative synthesis of tricuspid and CABG cases demonstrated low mortality. Conclusions Robotic redo mitral valve surgery is a safe, reproducible alternative to resternotomy. While outcomes for tricuspid and CABG procedures are promising, the evidence base remains primarily centred on mitral interventions. Future multi-centre prospective registries and large-scale comparative trials are required to definitively establish the long-term clinical and economic benefits of robotic redo cardiac surgery.
Reference Key
openalex_W7172512669 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shriya Karlapudi1, Kawal Rhode
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.600
URL
https://doi.org/10.1093/bjs/znag087.600
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.